KALBERMATTEN ADAM R 4

What Happened
Adam R. Kalbermatten, President and CEO of KORU Medical Systems (KRMD), received a grant of 286,697 performance stock units (PSUs) on July 1, 2026. The Form 4 reports these as a derivative award at $0.00 per share (no cash exchanged); the units convert to shares only if specified performance targets are met and the awards vest.

Key Details

• Transaction date: 2026-07-01; Form filed: 2026-07-02 (appears timely).
• Transaction type/code: Grant / Award (A).
• Units granted: 286,697 PSUs; reported price: $0.00; reported transaction value: $0.
• Vesting/conditions (footnote): 215,023 PSUs may vest based on the Company’s net sales growth on or prior to 12/31/2030; 71,674 PSUs may vest based on the Company’s market capitalization at 12/31/2030.
• Shares owned after transaction: not reported in the provided filing details.
• Remarks: Filing includes a standard disclaimer about beneficial ownership and notes a previously filed Power of Attorney.

Context
These are performance-based long-term incentive awards, not an open-market purchase or sale. They represent potential future dilution if performance goals are met and the PSUs vest and convert to stock. Because value realization depends on future targets and time (through 12/31/2030), the grant does not indicate immediate cash value or an immediate bullish/sell signal by the insider.